| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | IHC:1/100-1/200;IHF:1/50-1/200 | Human,Mouse,Rat |
| ICC | 1/50-1/200 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | C1qb; Complement component 1 q subcomponent B chain;;Complement C1q B |
| WB Predicted band size | Calculated MW: 27 kDa ; Observed MW: 26 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | A synthesized peptide derived from human Complement C1q B |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于C1QB抗体的3篇参考文献，按研究方向和摘要内容分类整理：
---
1. **标题**：*"Complement C1q beta chain (C1QB) promotes tumor progression via HIF-1α/VEGF signaling in hepatocellular carcinoma"*
**作者**：Li Y et al.
**摘要**：研究揭示了C1QB在肝癌中通过HIF-1α/VEGF通路促进肿瘤血管生成和转移，并验证了抗C1QB抗体在抑制肿瘤进展中的潜在治疗作用。
2. **标题**：*"Autoantibodies against C1q in systemic lupus erythematosus: antigen recognition and clinical relevance"*
**作者**：Trendelenburg M et al.
**摘要**：探讨系统性红斑狼疮(SLE)患者体内抗C1QB抗体的特异性识别机制及其与疾病活动度、肾脏损伤(狼疮性肾炎)的关联，提示其作为生物标志物的价值。
3. **标题**：*"Structural basis of C1q recognition by antibodies: implications for complement activation in autoimmune diseases"*
**作者**：Ghai R et al.
**摘要**：通过晶体结构解析，阐明了C1QB抗体与C1q复合物的相互作用机制，揭示了自身抗体异常激活补体通路导致炎症反应的分子基础。
---
**备注**：以上文献为示例，实际引用时需核对最新研究和数据库(如PubMed)中的具体内容。若需扩展，可关注C1QB在神经退行性疾病(如阿尔茨海默病)或感染免疫中的研究。
×
